Related Experiment Video

Updated: Oct 13, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Treatment of human immunodeficiency virus infection and its associated complications in children

M T Brady1

  • 1College of Medicine, Ohio State University, Columbus.

Journal of Clinical Pharmacology
|January 1, 1994
PubMed

Insights

Comprehensive care for human immunodeficiency virus (HIV)-infected children involves multidisciplinary support, managing complications, and antiretroviral therapy. Advances significantly improve quality of life and survival rates for pediatric HIV patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Virology

Background:

  • Human immunodeficiency virus (HIV) infection in children necessitates a multidisciplinary approach to care.
  • HIV impacts multiple organ systems, leading to diverse complications like opportunistic infections, malignancies, and direct organ damage.

Purpose of the Study:

  • To review current supportive care strategies for HIV-infected children.
  • To discuss the management of HIV-associated complications.
  • To examine the status of antiretroviral therapy in pediatric HIV.

Main Methods:

  • Literature review of recent scientific advances in pediatric HIV care.
  • Analysis of therapeutic interventions for HIV-related complications.
  • Evaluation of current and emerging antiretroviral therapies.

Main Results:

  • Prophylaxis for Pneumocystis carinii pneumonia is a critical therapeutic advance.
  • Advances in treating and preventing HIV-related infections improve survival and reduce hospitalizations.
  • Nucleoside reverse transcriptase inhibitors show efficacy, but limitations necessitate further research.

Conclusions:

  • Scientific advancements have substantially improved the quality and length of life for HIV-infected children.
  • Effective management requires a combination of supportive care, complication treatment, and optimized antiretroviral therapy.
  • Augmenting the immune response is a promising avenue for future HIV treatment regimens.

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...